Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of Pharmaceutical Investigation"
DOI: 10.1007/s40005-021-00534-y
Abstract: Cancer nanomedicines (NMs) have emerged as potential anticancer therapeutics with advantages of tumor-targeting drug delivery for improved efficacy against human solid tumors. Despite promising data obtained in preclinical studies, few clinical trials have demonstrated successful…
read more here.
Keywords:
preclinical evaluation;
based microtumor;
evaluation;
microtumor models ... See more keywords